Brief: Rossari Biotech Re-Appoints Sunil Chari As MD
29/04/2024 15:03
April 29 (Reuters) - Rossari Biotech Ltd ROSB.NS :
* RE-APPOINTMENT OF SUNIL CHARI AS MD
* ROSSARI BIOTECH MARCH-QUARTER CONSOL NET PROFIT 341.3
MILLION
RUPEES VERSUS PROFIT 289.8 MILLION RUPEES
* ROSSARI BIOTECH MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
4.73 BILLION RUPEES VERSUS 4.06 BILLION RUPEES
Further company coverage: ROSB.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Rossari Biotech
See all newsIndia's Rossari Biotech falls after ICICI Securities lowers PT
India's Rossari Biotech slips after Q1 net profit falls sequentially
Brief: Rossari Biotech Unit Commissions 15,000 MTPA Ethoxylation Capacity At Dahej
Brief: Rossari Biotech To Incorporate Subsidiary In Singapore With $10 Million Investment
India's Rossari Biotech gains on Q2 profit rise